Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Sets Its Sights On AI And Big Data For Medical Device Innovation

Executive Summary

In the FDA’s annual Focus Areas of Regulatory Science report, the agency lays out its areas of interest for the use of medical device advancement in public health and the research and development of medical devices.

You may also be interested in...



Hamilton Medical Recalls Intensive Care Ventilators Due To Hardware Issue

The US FDA has labelled a recall of intensive care ventilators from Hamilton Recall as class I, the agency’s most serious. A hardware issue could cause the machines to shut down.

Expert: Granting More Than 1 Year To Comply With QMSR Rule Puts FDA In A Pickle

Many commenters on the US FDA’s draft Quality Management System Regulation want two or three years to comply, but one medtech expert says that length of time could put the agency in a difficult position. Our coverage of the FDA’s draft QMSR – and an array of other news and analysis – topped our list of most-read Medtech Insight stories in May.

CDC Chooses Five Laboratories For Pathogen Genomics Network

The CDC’s $90m funding will be split among five laborites across the US over five years as a part of its pioneering Pathogen Genomics Centers of Excellence Network.

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145807

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel